Watts SW - Search Results

1

Arteries and veins desensitize differently to endothelin.

Thakali K, Fink GD, Watts SW. Thakali K, et al. Among authors: watts sw. J Cardiovasc Pharmacol. 2004 Mar;43(3):387-93. doi: 10.1097/00005344-200403000-00009. J Cardiovasc Pharmacol. 2004. PMID: 15076222

2

The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertensive rats.

Watts SW, Baez M, Webb RC. Watts SW, et al. J Pharmacol Exp Ther. 1996 May;277(2):1103-13. J Pharmacol Exp Ther. 1996. PMID: 8627522

3

Vascular gap junctional communication is increased in mineralocorticoid-salt hypertension.

Watts SW, Webb RC. Watts SW, et al. Hypertension. 1996 Nov;28(5):888-93. doi: 10.1161/01.hyp.28.5.888. Hypertension. 1996. PMID: 8901840

4

Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: use of the mitogen-activated protein kinase kinase inhibitor PD098059.

Watts SW. Watts SW. J Pharmacol Exp Ther. 1996 Dec;279(3):1541-50. J Pharmacol Exp Ther. 1996. PMID: 8968381

5

Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction.

Florian JA, Watts SW. Florian JA, et al. Among authors: watts sw. J Pharmacol Exp Ther. 1998 Jan;284(1):346-55. J Pharmacol Exp Ther. 1998. PMID: 9435197

6

The vascular reactivity of melatonin.

Monroe KK, Watts SW. Monroe KK, et al. Among authors: watts sw. Gen Pharmacol. 1998 Jan;30(1):31-5. doi: 10.1016/s0306-3623(97)00090-6. Gen Pharmacol. 1998. PMID: 9457478

7

The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension.

Watts SW. Watts SW. J Hypertens. 1998 Jun;16(6):811-22. doi: 10.1097/00004872-199816060-00012. J Hypertens. 1998. PMID: 9663921

8

Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction.

Watts SW, Florian JA, Monroe KM. Watts SW, et al. J Pharmacol Exp Ther. 1998 Sep;286(3):1431-8. J Pharmacol Exp Ther. 1998. PMID: 9732408

9

5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.

Watts SW, Fink GD. Watts SW, et al. Am J Physiol. 1999 Mar;276(3):H944-52. doi: 10.1152/ajpheart.1999.276.3.H944. Am J Physiol. 1999. PMID: 10070078

10

Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle.

Banes A, Florian JA, Watts SW. Banes A, et al. Among authors: watts sw. J Pharmacol Exp Ther. 1999 Dec;291(3):1179-87. J Pharmacol Exp Ther. 1999. PMID: 10565840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters